NCT07013695

Brief Summary

The VIRTUALR study evaluates the effect of virtual reality combined with hypnosis on anxiety in patients undergoing orthopedic surgery under regional anesthesia. Patients are randomly assigned to two groups: one group receiving virtual reality and a control group without the device. Anxiety and satisfaction questionnaires are used to compare the two groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 10, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2025

Completed
Last Updated

June 10, 2025

Status Verified

June 1, 2025

Enrollment Period

12 months

First QC Date

May 22, 2025

Last Update Submit

June 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of sedation use rates between the experimental group and the control group (level 0 versus ≥1).

    Proportion of patients who required sedation (at level ≥1) during regional anesthesia or surgery, compared to those who did not receive sedation (level 0). Sedation levels are defined according to a standardized scale.

    Intraoperative period (from arrival in the operating room to the end of surgery)

Secondary Outcomes (4)

  • Mean age of patients

    Baseline (before anesthesia consultation or at inclusion)

  • Sex distribution

    Baseline (before anesthesia consultation or at inclusion)

  • type of surgery

    Baseline (before anesthesia consultation or at inclusion)

  • ASA score distribution

    Baseline (before anesthesia consultation or at inclusion)

Study Arms (2)

virtual reality group

ACTIVE COMPARATOR

Participants in this group receive a virtual reality session with a hypnotic objective during surgery performed under regional anesthesia. The device consists of a virtual reality headset offering immersive visual and auditory content in a calming environment chosen by the participant. The session begins before the administration of regional anesthesia and may continue throughout the surgical procedure.

Device: Virtual reality headset

Control Group

PLACEBO COMPARATOR

Participants in this group receive standard anesthetic and surgical care without the use of virtual reality.

Other: Standard Care (in control arm)

Interventions

Patients in the intervention group receive a virtual reality session with a hypnotic purpose during surgery under regional anesthesia. The device consists of a virtual reality headset providing visual and auditory immersion in a calming environment, freely chosen by the patient. The session begins before the regional anesthesia is administered and may continue throughout the entire surgical procedure

virtual reality group

Participants in this group receive standard anesthetic and surgical care without the use of virtual reality

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent
  • Patient affiliated with or benefiting from a social security system
  • Patient aged 18 years or older
  • Patient requiring regional anesthesia for scheduled orthopedic surgery of the upper or lower limb

You may not qualify if:

  • Patient refusal to participate in the study
  • Device interfering with the surgical or anesthetic procedure
  • Premedication before arrival in the operating room
  • Psychiatric or cognitive disorders, communication disorders
  • Patient unable to understand the study (language barrier, psychological issues)
  • Emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Eure-Seine

Évreux, 27000, France

RECRUITING

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jean-Baptiste HARDY

    Centre Hospitalier Eure-Seine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomized parallel-group study with two arms (virtual reality group vs. control group) comparing the effect of virtual reality on sedation use during regional anesthesia.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2025

First Posted

June 10, 2025

Study Start

July 18, 2024

Primary Completion

July 17, 2025

Study Completion

July 19, 2025

Last Updated

June 10, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations